{"id":"W3166632772","doi":"10.1200/jco.2021.39.15_suppl.1048","title":"Real-world cost-effectiveness of pertuzumab (P) with trastuzumab + chemo (T+Chemo) in patients (pts) with metastatic breast cancer (MBC): A population-based retrospective cohort study by the Canadian Real-world Evidence for Value in Cancer Drugs (CanREValue) collaboration.","year":2021,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"Sunnybrook Health Science Centre; Institute for Clinical Evaluative Sciences; Cancer Care Ontario; Centre for Addiction and Mental Health; Ontario Institute for Cancer Research; University of Toronto","funders":"","keywords":"Medicine; Hazard ratio; Population; Cohort; Pertuzumab; Internal medicine; Cancer registry; Breast cancer; Propensity score matching; Trastuzumab; Cancer; Oncology; Demography; Environmental health; Confidence interval","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"observational","genre":"empirical","about_ca_system":false,"about_ca_topic":true,"confidence":"high","status":"direct model label, unvalidated"},{"model":"gpt","categories":[],"domain":null,"study_design":"observational","genre":"empirical","about_ca_system":true,"about_ca_topic":true,"confidence":"high","status":"direct model label, unvalidated"}],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001091156,0.0002679062,0.0004047908,0.0006804548,0.0004640828,0.001052147,0.0007711436,0.0005264936,0.001376959],"category_scores_gemma":[0.004557148,0.0002858505,0.001496647,0.001953855,0.0003829098,0.0004630856,0.0006049224,0.0007182409,0.0001586763],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.009906876,"about_ca_system_score_gemma":0.00483151,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.5626369,"about_ca_topic_score_gemma":0.5906157,"domain_scores_codex":[0.9989906,0.0002424566,0.0001324518,0.0001718402,0.0002501585,0.0002125],"domain_scores_gemma":[0.9974049,0.0003555008,0.001532192,0.0001286721,0.0002785875,0.0003002016],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.002173827,0.0001761044,0.9900782,0.000144082,0.001398409,0.0001214256,0.000131114,0.0007504136,0.0001092801,0.0001661144,0.001124423,0.003626589],"study_design_scores_gemma":[0.0004957095,0.0006763709,0.9937308,0.0001022602,0.0009470062,0.000265442,0.0003137386,0.001511235,0.00008239636,0.0001105819,0.001740966,0.00002370846],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9902739,0.0008903501,0.0000743854,0.0002155556,0.000007384789,0.00009570804,0.007870561,0.000003079601,0.0005690564],"genre_scores_gemma":[0.9948289,0.0004264347,0.0001705621,0.0001014056,0.00000994077,0.00006138807,0.004229994,0.000001958563,0.0001694169],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4373631,"threshold_uncertainty_score":0.8798777,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.312049489365141,"score_gpt":0.5283286827249328,"score_spread":0.2162791933597918,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}